Nadolol and Bendroflumethiazide (Impax Generics)
Welcome to the PulseAid listing for the Nadolol and Bendroflumethiazide drug offered from Impax Generics. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Impax Generics |
| NON-PROPRIETARY NAME: | NADOLOL and BENDROFLUMETHIAZIDE |
| SUBSTANCE NAME: | NADOLOL; BENDROFLUMETHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2007-03-30 |
| END MARKETING DATE: | 0000-00-00 |
Nadolol and Bendroflumethiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nadolol and Bendroflumethiazide from Impax Generics |
| LABELER NAME: | Impax Generics |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 40; 5(mg/1; mg/1) |
| START MARKETING DATE: | 2007-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0115-5311_2669933a-33f4-478a-bd9d-9fe48429bcc9 |
| PRODUCT NDC: | 0115-5311 |
| APPLICATION NUMBER: | ANDA077833 |
Other NADOLOL; BENDROFLUMETHIAZIDE Pharmaceutical Manufacturers / Labelers:
